funding round
Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human lifespan
Micheal
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year. ...
Exclusive: Tokenization startup Plume gets $20 million in funding to build a real-world asset finance ecosystem
Micheal
Plume facilitates real-world asset financing through its native blockchain. Read More
